Research and Markets: 2014 Report on the International Home Healthcare (Web - Based, On - Premises, Cloud) Software Market - Forecast to 2018

DUBLIN--Research and Markets (http://www.researchandmarkets.com/research/n7nkh8/home_healthcare) has announced the addition of the "2014 Report on the International Home Healthcare (Web - Based, On - Premises, Cloud) Software Market - Forecast to 2018" report to their offering.

Several initiatives and healthcare reforms have been developed in order to support the adoption and implementation of homecare software, especially hospital readmission program by Affordable Care Act, and new health plan budget approved by Obama's care where reimbursement value is cut down by 1.1%.

Clinical management system accounted for the largest share-35%- of global home healthcare software and services market. Clinical Management system and telehealth solutions are estimated to grow at brisk pace over the next five years. The high growth in these segments can be attributed to the growing demand for quality care at point-of-care, real time access of patient's data, and rising medication errors. Furthermore, the implementation of this system will help in reducing healthcare costs, and re-admission rates.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Premium Insights

4 Market Overview

5 Global Home Healthcare Software & Services Market, By Product Type

6 Global Home Healthcare Software & Services, By Application

7 Global Home Healthcare Market, By Mode Of Usage

8 Global Home Healthcare Software & Services Market, By Delivery Mode

9 Global Home Healhcare Software & Services Market, By Component

10 Global Home Healthcare Software & Services Market, By End User

11 Geographic Analysis

12 Competitive Landscape

13 Company Profiles

Companies Mentioned:

  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Continulink Llc
  • Delta Health Technologies
  • Hearst Corporation
  • Healthmedx
  • Kinnser Software, Inc.
  • Mckesson Corporation
  • Medical Information Technology, Inc. (Meditech)
  • Thornberry Limited

For more information visit http://www.researchandmarkets.com/research/n7nkh8/home_healthcare

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.